PharmaTalkRadio

Patients are at the center of research and their data is the foundation for clinical innovation. However, significant barriers exist that inhibit the secure and efficient sharing of patient data. In this podcast, Craig Lipset, Head of Clinical Innovation, Pfizer, Munther Barra, Head of New Clinical Paradigm, Pfizer and Aditya Kudumala, Principal, Deloitte discuss blockchain as a catalyst to significantly change how we can access and use data to improve patient lives. Where is the patient data storm going?

Discussion points include, but not limited to:

Who owns my data and where it’s going?What are the interoperability challenges and progress?How can data be shared?How you can pull in your own health data?Where does blockchain fit in and how can it secure patient data?  How blockchain gives us authentication without identification?Next steps? 

For more information on this topic and to get access to the Blockchain Opportunities for Patient Data Donation & Cinical Research, click here. 

Craig will be leading an entire section on the democratization of patient data at DPharm on September 25-26 in Boston.

This 8 minute podcast gives you an overview on what to expect from the 8th annual DPharm conference. DPharm is the annual event in the US to get the best access to innovative ideas, especially disruptive ones, to advance clinical trials with a view to reducing the burden to patients and investigators.

DPharm 2018 is dedicated to all things digital, data science, patient data ownership and new approaches to optimize clinical operation systems.

DPharm is September 25-26 at the Boston Marriott Copley Place.

Chaired by:

Sylke Poehling, PhD, SVP and Global Head, Strategy, Portfolio & Clinical Operations, Pharma Research & Early Development, Roche

Andreas Koester, MD, PhD, VP and Global Head, Janssen Clinical Innovation, Janssen

Craig Lipset, MBA, Head of Clinical Innovation, Pfizer

For more information visit www.theconferenceforum.org

Producer: Valerie Bowling, Executive Director, DPharm

Welcome to the 5th annual Mobile in Clinical Trials podcast. In this quick fire podcast, you will get a brief overview on what to expect. The conference takes place in Boston on Sept 24th, the day before DPharm. It is researched and produced by the Conference Forum and is chaired by: 

Daniel Karlin, MD

Assistant Professor of Psychiatry, Tufts University and Former Head of Clinical, Informatics, and Regulatory Strategy, Digital Medicine, Pfizer Inc

Mobile and digital tools are the future of clinical trials and as the industry continues to transition into a data science industry with a responsibility to reduce patient burden, it is really important that we bring this conference to you to get the latest examples on what tools are available and who has used them and what are the lessons to engage patients?

For more information, visit www.theconferenceforum.org

Producers: Valerie Bowling, Executive Director, the Conference Forum and Jennifer Moran, Producer, the Conference Forum

Rational Combinations 360° addresses business aspects, clinical advancements and scientific data in IO combination strategies. The rapid advancement in our understanding of human cancer immunity and immunotherapy combinations is nearly impossible for individual scientists to comprehend. Only together, as an engaged and interactive scientific community, can we hope to enable a patient’s immune system to eradicate cancer.

Rational Combinations 360° addresses the following plenary topics over the course of 2 days:

Discovery and Preclinical ScienceTranslational Science and Emerging BiomarkersOperationalizing IO CombinationsEmerging Clinical CombinationsEmerging Data Combinations in Clinical TrialsBusiness Aspects

Dr Patrick Hwu, MD Anderson, Dr Axel Hoos, GSK and Dr Ian McCaffery, Janssen, together led the design of the 3rd annual program that includes more than 45 speakers and over 30 talks.

For more information about Rational Combinations 360°, visit, www.theconferenceforum.org. Be sure to use code TEML for a 10% discount. Thanks for listening.

How to Innovate in the Drug Delivery Space

What does the innovation process look likeThe barrier to the innovation process and how to overcomethemSummary of disease spaceGood design and engineering practicesHow to salvage something that goes wrong?How do you find the unknown unknowns?Does it feel right?

Uri Baruch

Head of Drug Delivery, Cambridge Design Partnership

This talk was given at the 2018 Drug Delivery West Meeting.

Opening talk at Drug Delivery West, 2018

Key Trends in Drug Delivery: Expert Perspective

Randall Mrsny, PhD

Professor's Chair, Department of Pharmacy and Pharmacology,

University of Bath

Patients as Partners Day 2 Session

How FARA and Horizon Pharma Partnered to Improve Clinical Development and Trial Design-Case Study

This session will feature how the Friedreich’s Ataxia Research Foundation collaborated with Horizon Pharma on aspects of clinical development and trial design to better understand patients living with the disease and how to better develop medicine to help manage their disease. Key areas of discussion include how they collaborated on the following:

• Focus groups to better understand drug administration • Clinical trial design to ensure feasibility and efficiency • Recruiting patients for clinical trials

• Open discussion at FDA meetings

Kyle Bryant

Director of the Bicycle Ride Fundraiser, rideAtaxia for the Friedreich’s Ataxia Research Alliance (FARA) 

Robert Metz

SVP, Global Business Operations and External Affairs, Horizon Pharma

This talk was given at the Patients as Partners 2018 Meeting

There are many frameworks and models that exist from various organizations on aspects of patient engagement and may be challenging to navigate through when applying to your own initiatives. In this session, Takeda will walk the audience through how they used multiple patient engagement frameworks to create an internal R&D Patient Engagement Guide tailored for their drug development teams from discovery through marketed products. The audience will learn how the guide has help build support and a cultural shift for Takeda’s internal patient engagement initiatives and how it has helped each team at various phases of development with the following:

• Identifying what the patient engagement activities are at the different phases of development • How does patient engagement apply to the work I am doing?

• Identifying who is relevant to talk to, how to go about it

• What is the impact?

• Mapping the patient advocacy landscape

• Identifying what all the ways are that teams can learn from patients

• What you need to understand about patient advocacy groups before engaging with them • How to initiate relationships with patient advocacy

• Understanding where patients fit in your development, where online communities fit in, etc

• Implementing change and streamlining patient engagement initiatives internally

• Identifying each team’s key patient engagement issues

• Training teams on creating and documenting patient engagement plans

• Demonstrating how to integrate patient engagement plans with overall development plans • Helping initiate activities

Carol Meyer, R&D Patient Engagement Lead, Takeda Pharmaceuticals

This talk was given at the Patients as Partners 2018 Meeting

How Patient Research Advocates are Driving R&D: A Patient Case Study

In this session, patient and research advocate, Geraldine Blavat will walk the audience through 10 steps on how patient input is integrated through the entire clinical development continuum including:

Developing the Study Concept

Secure Funding

Preparing the Study Protocol

Creating Study Procedure

Implementing the Study

Monitoring the Study

Analyzing the Data and Interpreting Results

Disseminating Study Information

FDA Review and Approval

Post Approval Studies

This talk was given by Geraldine Blavat, Parkinson’s Foundation Research Advocate and

Karlin Schroeder, Director, Community Engagement, Parkinson’s Foundation

Join us this year at the 6th annual Patients as Partners US event, taking place March 11-12, 2019 in Philadelphia.

John Patton, PhD, Chief Executive Officer and Chairman with Dance Biopharma and Ann Daugherty, PhD, Senior Manager, Drug Delivery with Genentech present the closing talk at Drug Delivery West, held May 21-22, 2018 in San Francisco.  In this talk they discuss the lessons learned from drug delivery, what to be aware of in the future, and how to improve drug delivery methods.  The next conference in Drug Delivery is the 8th annual PODD: Partnership Opportunities in Drug Delivery on October 17-18, 2018 in Boston. For more information, visit www.theconferenceforum.org